EICHORCondition: Heart Failure · Biventricular Failure · Sponsor: BiVACOR Inc.
Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.
The purpose of this study is to assess the feasibility of using the BiVACOR Total Artificial Heart (TAH) System to support adult patients with severe biventricular heart failure, or univentricular heart failure in which left ventricular assist device (LVAD) support is not recommended, who require mechanical circulatory support to sustain life. The BiVACOR TAH System is intended for use as a bridge to transplant (BTT). Feasibility will be assessed by evaluating safety and performance of the BiVACOR TAH System in study subjects.
This description comes directly from the study's public registry record.
Dennis Kirven · 804-461-1299 · dennis.kirven@bivacor.com
Diane Covington · 480-794-0232 · dcovington@crconcepts-cro.com
Always discuss trial participation with your own doctor first.
| Banner - University Medical Center Phoenix | Phoenix, Arizona, United States | Recruiting |
| Duke University Hospital | Durham, North Carolina, United States | Recruiting |
| The Christ Hospital | Cincinnati, Ohio, United States | Recruiting |
| Texas Heart Institute / Baylor St. Luke's Medical Center | Houston, Texas, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06174103